Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is taken as a once-weekly subcutaneous injection using a pre-filled KwikPen, with each pen containing four doses. You inject into the fatty layer just beneath the skin of your abdomen, thigh or upper arm, rotating the site each week. As a prescription-only medicine, it must be prescribed following a clinical assessment. Here is what the instructions actually look like in practice, and what tends to trip people up.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common assumption is that because Mounjaro comes in a pre-filled, pre-set pen, there is nothing much to learn. The KwikPen is genuinely straightforward, but that ease can lead people to skip a few steps that actually matter. Holding the pen at the wrong angle, not keeping it pressed against the skin for long enough after pressing the button, or pulling away before the dose has fully delivered are the most frequent mistakes our prescribers hear about. None of them are complicated to fix once you know to look for them.
If you want a clear walkthrough before your first injection, our guide on how you take tirzepatide covers the full technique in plain language. The NHS tirzepatide medicine page links to demonstration resources, and your Patient Information Leaflet walks through each step with diagrams. Reading it once properly is genuinely worth the ten minutes.
Mounjaro does not require you to dial a dose yourself. Each pen is preset to its strength, so there is no way to accidentally draw up the wrong amount. That is one real advantage of the KwikPen format. What you do control is site rotation, skin preparation and the hold time after injection, all small things that add up.
Mounjaro is taken once a week, and our page on how often you take Mounjaro explains why keeping the interval close to seven days helps the medicine work at its best. If you shift your day occasionally by a day or so, that is manageable, check the Patient Information Leaflet for guidance on how far the timing can flex, and contact your prescriber if you are unsure after a longer gap. Questions about missed doses or changing your injection day are exactly the kind of thing our support team is available seven days a week to help with.
A practical anchor helps. Some people tie the injection to a fixed weekly routine: the same evening they do their grocery order, the morning before a regular weekend activity. It becomes habit quickly. The pen lives in the fridge door, which makes forgetting it harder than remembering it.
One thing worth knowing: you can take Mounjaro at any time of day, with or without food. Unlike the oral semaglutide tablet, there are no fasting requirements around the Mounjaro injection. That flexibility is useful. You can find a broader comparison of how tirzepatide works as a dual GIP and GLP-1 receptor agonist if you want more background on the mechanism behind the weekly schedule.
The three approved sites are the abdomen (avoiding a small area around the navel), the front of the thigh, and the outer upper arm. Rotating between them each week prevents localised reactions from building up, a small, firm patch under the skin at one spot is the usual sign that it has been overused. The rotation does not need to follow a rigid sequence; just avoid the same spot two weeks running.
Storage is straightforward between uses: the fridge, at 2°C to 8°C, away from the freezer compartment. A frozen pen must not be used. The Patient Information Leaflet specifies exactly how long the pen can sit at room temperature and remain usable, a detail worth checking before travel or before leaving it on a bedside table. If you are thinking about the cost of ongoing treatment alongside questions about technique, our Mounjaro cost page sets out what private prescriptions typically include.
Needles are already attached to the KwikPen and are single-use. After each injection, replace the cap and dispose of the used pen in a sharps container, not the household bin. Your prescriber or pharmacist can advise on local sharps disposal routes. For more on the administration process in detail, our page on how you take Mounjaro covers the full sequence alongside the step-by-step guide to using Mounjaro.
The Patient Information Leaflet and this page can explain how Mounjaro is administered. What they cannot do is tell you which dose is right for you, when your dose should increase, or whether to continue if you are finding the side effects difficult. Those decisions belong to the clinician who reviewed your consultation.
Treatment begins at 2.5mg. That starting strength exists not because 2.5mg produces significant weight loss on its own (it does not) but because it gives your body time to adjust to the medicine before the dose rises. The NICE appraisal of tirzepatide, published as TA1026, is the clinical foundation behind how this medicine is recommended in the UK. Dose increases happen at intervals your prescriber sets, based on how you are tolerating treatment and your progress. Trying to speed that up by using a higher-strength pen than prescribed is not safe, and it is not something a reputable pharmacy would support.
Side effects are most noticeable in the days after starting or after a dose increase. Nausea, loose stools and reduced appetite are the most reported. They tend to settle. If they do not, or if you experience severe stomach pain that spreads to your back, seek medical help promptly, this is one of the symptoms highlighted in MHRA safety guidance on GLP-1 medicines. If you are considering whether Mounjaro is the right treatment for you, speaking to our prescribers is the sensible next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.